Area of research
Safety, Risk, Reliability and Quality · Cancer Research
Research interest
Research interests include Biology, Cell biology, Translation (biology), mTORC1, PI3K/AKT/mTOR pathway, and Ribosome.
Age‐dependent loss of hepatic <scp>SIRT1</scp> enhances NLRP3 inflammasome signaling and impairs capacity for liver fibrosis resolution
Targeting hepatic serine-arginine protein kinase 2 ameliorates alcohol-associated liver disease by alternative splicing control of lipogenesis
4E-BP–Dependent Translational Control of <i>Irf8</i> Mediates Adipose Tissue Macrophage Inflammatory Response
Hepatic posttranscriptional network comprised of CCR4–NOT deadenylase and FGF21 maintains systemic metabolic homeostasis
Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides
Translational control of ERK signaling through miRNA/4EHP-directed silencing
mTOR Controls Mitochondrial Dynamics and Cell Survival via MTFP1
Translation is actively regulated during the differentiation of CD8+ effector T cells
mTOR coordinates protein synthesis, mitochondrial activity and proliferation
Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale
Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale
mTORC1 Controls Mitochondrial Activity and Biogenesis through 4E-BP-Dependent Translational Regulation
Distinct perturbation of the translatome by the antidiabetic drug metformin
A Novel 4EHP-GIGYF2 Translational Repressor Complex Is Essential for Mammalian Development